National baseline report on Quality Use of Medicines and Medicines Safety - Phase 1: Residential aged care
In November 2019, the Council of Australian Governments (COAG) Health Council made Quality Use of Medicines and Medicines Safety the 10th National Health Priority Area. The Commission was subsequently engaged to develop a national baseline report on the Quality Use of Medicines and Medicines Safety, with an initial focus on aged care.
Accessibility - We aim to provide documents in an accessible format. If you're having problems using a document with your accessibility tools, please contact us for help.
Copyright - Unless stated otherwise, materials provided are covered by a Creative Commons Attribution-Non-Commercial-Share Alike (BY-NC-ND) 4.0 International License.
The Commission was assigned the responsibility of drafting the national baseline report on Quality Use of Medicines and Medicine Safety to inform new best practice models, new national standards and better medication management. The work to develop the national baseline report is divided into two Phases:
- Phase 1 focussed on aged care and issues of polypharmacy, use of antipsychotic medicines and transitions of care
- Phase 2 will investigate the broader issues of Quality Use of Medicines and Medicine Safety, as well as issues of medication safety during transitions of care.
The result of Phase 1 is this National Baseline Report on Quality Use of Medicines and Medicines Safety – Phase 1 Residential aged care. The Report identifies a potential roadmap to embed Quality Use of Medicine principles in the aged care sector, with the aim of reducing medication-related harm.